Gene expression changes in spinal motoneurons of the SOD1G93A transgenic model for ALS after treatment with G-CSF

Frontiers in Cellular Neuroscience

Volumn 8, Issue JAN, 2015, Pages 1-12

  Henriques, Alexandre ^a,b   Kastner, Stefan ^c   Chatzikonstantinou, Eva ^c   Pitzer, Claudia ^c   Plaas, Christian ^c   Kirsch, Friederike ^c   Wafzig, Oliver ^c   Krüger, Carola ^c   Spoelgen, Robert ^c   de Aguilar, Jose Luis Gonzalez ^a,b   Gretz, Norbert ^d   Schneider, Armin ^c  

^a Laboratoire des Mecanismes Centraux et Peripheriques de la Neurodegenerescence   (France)

^b UNIVERSITÉ DE STRASBOURG   (France)

^c Sygnis Bioscience GmbH and Co KG   (Germany)

^d UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

ALS; G CSF; Gene expression; Laser microdissection; Motoneuron; Mouse model; Neurodegeneration

Indexed keywords

ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE 1; ALDEHYDE OXIDASE 1; ATAXIN 2; CATHEPSIN X; CHEMOKINE RECEPTOR CCR4; CHONDROLECTIN; COLLECTIN SUB FAMILY MEMBER 11; DYNEIN AXONEMAL HEAVY CHAIN 2 PROTEIN; EGF LIKE DOMAIN MULTIPLE 6 PROTEIN; FIBROBLAST GROWTH FACTOR 21; GLIAL FIBRILLARY ACIDIC PROTEIN; GRANULOCYTE COLONY STIMULATING FACTOR; GROWTH ARREST AND DNA DAMAGE INDUCIBLE 45 ALPHA PROTEIN; IMMUNOGLOBULIN HEAVY CHAIN; INTEGRAL MEMBRANE PROTEIN 2A; LECTIN GALACTOSE BINDING SOLUBLE 3 PROTEIN; LEUCINE ZIPPER DOWN REGULATED IN CANCER 1 PROTEIN; MESSENGER RNA; NERVE PROTEIN; NUCLEAR PROTEIN 1; PLACEBO; PROTEIN KINASE WNK4; PROTEIN TYROSINE PHOSPHATASE RECEPTOR TYPE D; RECEPTOR ACCESSORY PROTEIN 1; SECRETED PHOSPHOPROTEIN 2; SEVEN IN ABSENTIA 1A PROTEIN; STARCH BINDING DOMAIN 1; TRANSCRIPTOME; UNCLASSIFIED DRUG; UNINDEXED DRUG; VACUOLAR PROTEIN SORTING 4B;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASYMPTOMATIC DISEASE; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; DRUG EFFICACY; DRUG MECHANISM; FEMALE; GENE; GENE AMPLIFICATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE ONTOLOGY; GENETIC REGULATION; GENETIC TRANSCRIPTION; HISTOPATHOLOGY; HUMAN; LASER MICRODISSECTION; MALE; MOUSE; MSOD1 MOUSE; NEPHROBLASTOMA OVEREXPRESSED GENE; NERVE DEGENERATION; NEUROMUSCULAR FUNCTION; NONHUMAN; PREDICTED GENE 20245; PRSS12 GENE; REAL TIME POLYMERASE CHAIN REACTION; RNA ISOLATION; SPINAL CORD MOTONEURON; TRANSCRIPTOMICS; UPREGULATION;

EID: 84921875307     PISSN: 16625102     EISSN: None     Source Type: Journal    
DOI: 10.3389/fncel.2014.00464     Document Type: Article

References (63)

1. Averill, S., Michael, G. J., Shortland, P. J., Leavesley, R. C., King, V. R., and Bradbury, E. J. (2004). NGF and GDNF ameliorate the increase in ATF3 expression which occurs in dorsal root ganglion cells in response to peripheral nerve injury. Eur. J. Neurosci. 19, 1437-1445. doi: 10. 1111/j. 1460-9568. 2004. 03241. x.
2. Bandyopadhyay, U., Cotney, J., Nagy, M., Oh, S., Leng, J., Mahajan, M., et al. (2013). RNA-Seq profiling of spinal cord motor neurons from a presymptomatic SOD1 ALS mouse. PLoS ONE 8: e53575. doi: 10. 1371/journal. pone. 0053575.
3. Blasco, H., Corcia, P., Moreau, C., Veau, S., Fournier, C., Vourc'h, P., et al. (2010). 1H-NMR-based metabolomic profiling of CSF in early amyotrophic lateral sclerosis. PLoS ONE 5: e13223. doi: 10. 1371/journal. pone. 0013223.
4. Bonilla, I. E., Tanabe, K., and Strittmatter, S. M. (2002). Small proline-rich repeat protein 1A is expressed by axotomized neurons and promotes axonal outgrowth. J. Neurosci. 22, 1303-1315.
5. Cahoy, J. D., Emery, B., Kaushal, A., Foo, L. C., Zamanian, J. L., Christopherson, K. S., et al. (2008). A transcriptome database for astrocytes, neurons, and oligodendrocytes: a new resource for understanding brain development and function. J. Neurosci. 28, 264-278. doi: 10. 1523/JNEUROSCI. 4178-07. 2008.
6. Cassina, P., Pehar, M., Vargas, M. R., Castellanos, R., Barbeito, A. G., Estevez, A. G., et al. (2005). Astrocyte activation by fibroblast growth factor-1 and motor neuron apoptosis: implications for amyotrophic lateral sclerosis. J. Neurochem. 93, 38-46. doi: 10. 1111/j. 1471-4159. 2004. 02984. x.
7. Chen, L. J., Ren, Y. H., Liu, L., Zhang, X. Q., Zhao, Y., Wu, W. T., et al. (2010). Upregulated expression of GAP-43 mRNA and protein in anterior horn motoneurons of the spinal cord after brachial plexus injury. Arch. Med. Res. 41, 513-518. doi: 10. 1016/j. arcmed. 2010. 10. 005.
8. Chio, A., Mora, G., La Bella, V., Caponnetto, C., Mancardi, G., Sabatelli, M., et al. (2011). Repeated courses of granulocyte colony-stimulating factor in amyotrophic lateral sclerosis: clinical and biological results from a prospective multicenter study. Muscle Nerve 43, 189-195. doi: 10. 1002/mus. 21851.
9. Collart, M. A., and Panasenko, O. O. (2012). The Ccr4-not complex. Gene 492, 42-53. doi: 10. 1016/j. gene. 2011. 09. 033.
10. Cuevas, P., Carceller, F., and Gimenez-Gallego, G. (1995). Acidic fibroblast growth factor prevents post-axotomy neuronal death of the newborn rat facial nerve. Neurosci. Lett. 197, 183-186. doi: 10. 1016/0304-3940(95)11926-N.
11. Cui, G., Wang, Y., Yu, S., Yang, L., Li, B., Wang, W., et al. (2014). The expression changes of vacuolar protein sorting 4B (VPS4B) following middle cerebral artery occlusion (MCAO) in adult rats brain hippocampus. Cell. Mol. Neurobiol. 34, 83-94. doi: 10. 1007/s10571-013-9989-5.
12. Dorst, J., Cypionka, J., and Ludolph, A. C. (2013). High-caloric food supplements in the treatment of amyotrophic lateral sclerosis: a prospective interventional study. Amyotroph. Lateral Scler. Frontotemporal Degener. 14, 533-536. doi: 10. 3109/21678421. 2013. 823999.
13. Duning, T., Schiffbauer, H., Warnecke, T., Mohammadi, S., Floel, A., Kolpatzik, K., et al. (2011). G-CSF prevents the progression of structural disintegration of white matter tracts in amyotrophic lateral sclerosis: a pilot trial. PLoS ONE 6: e17770. doi: 10. 1371/journal. pone. 0017770.
14. Ferraiuolo, L., Heath, P. R., Holden, H., Kasher, P., Kirby, J., and Shaw, P. J. (2007). Microarray analysis of the cellular pathways involved in the adaptation to and progression of motor neuron injury in the SOD1G93A mouse model of familial ALS. J. Neurosci. 27, 9201-9219. doi: 10. 1523/JNEUROSCI. 1470-07. 2007.
15. Frey, D., Schneider, C., Xu, L., Borg, J., Spooren, W., and Caroni, P. (2000). Early and selective loss of neuromuscular synapse subtypes with low sprouting competence in motoneuron diseases. J. Neurosci. 20, 2534-2542.
16. Gordon, P. H. (2013). Amyotrophic lateral sclerosis: an update for 2013 clinical features, pathophysiology, management and therapeutic trials. Aging Disease 4, 295-310. doi: 10. 14336/AD. 2013. 0400295.
17. Grasselli, G., Mandolesi, G., Strata, P., and Cesare, P. (2011). Impaired sprouting and axonal atrophy in cerebellar climbing fibres following in vivo silencing of the growth-associated protein GAP-43. PLoS ONE 6: e20791. doi: 10. 1371/journal. pone. 0020791.
18. Gurney, M. E., Pu, H., Chiu, A. Y., Dal Canto, M. C., Polchow, C. Y., Alexander, D. D., et al. (1994). Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science 264, 1772-1775. doi: 10. 1126/science. 8209258.
19. Guzman, M., and Blazquez, C. (2004). Ketone body synthesis in the brain: possible neuroprotective effects. Prostaglandins Leukot. Essent. Fatty Acids 70, 287-292. doi: 10. 1016/j. plefa. 2003. 05. 001.
20. Han, J. H., Ryu, H. H., Jun, M. H., Jang, D. J., and Lee, J. A. (2012). The functional analysis of the CHMP2B missense mutation associated with neurodegenerative diseases in the endo-lysosomal pathway. Biochem. Biophys. Res. Commun. 421, 544-549. doi: 10. 1016/j. bbrc. 2012. 04. 041.
21. Han, W., Lou, Y., Tang, J., Zhang, Y., Chen, Y., Li, Y., et al. (2001). Molecular cloning and characterization of chemokine-like factor 1 (CKLF1), a novel human cytokine with unique structure and potential chemotactic activity. Biochem. J. 357(Pt 1), 127-135. doi: 10. 1042/0264-6021: 3570127.
22. Harr, B., and Schlotterer, C. (2006). Comparison of algorithms for the analysis of Affymetrix microarray data as evaluated by co-expression of genes in known operons. Nucleic Acids Res. 34: e8. doi: 10. 1093/nar/gnj010.
23. Henriques, A., and Gonzalez De Aguilar, J. L. (2011). Can transcriptomics cut the gordian knot of amyotrophic lateral sclerosis? Curr. Genomics 12, 506-515. doi: 10. 2174/138920211797904043.
24. Henriques, A., Pitzer, C., Dittgen, T., Klugmann, M., Dupuis, L., and Schneider, A. (2011). CNS-targeted viral delivery of G-CSF in an animal model for ALS: improved efficacy and preservation of the neuromuscular unit. Mol. Therapy 19, 284-292. doi: 10. 1038/mt. 2010. 271.
25. Henriques, A., Pitzer, C., Dupuis, L., and Schneider, A. (2010a). G-CSF protects motoneurons against axotomy-induced apoptotic death in neonatal mice. BMC Neurosci. 11: 25. doi: 10. 1186/1471-2202-11-25.
26. Henriques, A., Pitzer, C., and Schneider, A. (2010b). Neurotrophic growth factors for the treatment of amyotrophic lateral sclerosis: where do we stand? Front. Neurosci. 4: 32. doi: 10. 3389/fnins. 2010. 00032.
27. Higashi-Kovtun, M. E., Mosca, T. J., Dickman, D. K., Meinertzhagen, I. A., and Schwarz, T. L. (2010). Importin-beta11 regulates synaptic phosphorylated mothers against decapentaplegic, and thereby influences synaptic development and function at the Drosophila neuromuscular junction. J. Neurosci. 30, 5253-5268. doi: 10. 1523/JNEUROSCI. 3739-09. 2010.
28. Huang, H., and Trussell, L. O. (2011). KCNQ5 channels control resting properties and release probability of a synapse. Nat. Neurosci. 14, 840-847. doi: 10. 1038/nn. 2830.
29. Hyatt Sachs, H., Schreiber, R. C., Shoemaker, S. E., Sabe, A., Reed, E., and Zigmond, R. E. (2007). Activating transcription factor 3 induction in sympathetic neurons after axotomy: response to decreased neurotrophin availability. Neuroscience 150, 887-897. doi: 10. 1016/j. neuroscience. 2007. 10. 008.
30. Kikuchi, H., Yamada, T., Furuya, H., Doh-ura, K., Ohyagi, Y., Iwaki, T., et al. (2003). Involvement of cathepsin B in the motor neuron degeneration of amyotrophic lateral sclerosis. Acta Neuropathol. 105, 462-468. doi: 10. 1007/s00401-002-0667-9.
31. Kobbe, G., Bruns, I., Fenk, R., Czibere, A., and Haas, R. (2009). Pegfilgrastim for PBSC mobilization and autologous haematopoietic SCT. Bone Marrow Transplant. 43, 669-677. doi: 10. 1038/bmt. 2009. 59.
32. Kruger, K., Pilat, C., Schild, M., Lindner, N., Frech, T., Muders, K., et al. (2014). Progenitor cell mobilization after exercise is related to systemic levels of G-CSF and muscle damage. Scand. J. Med. Sci. Sports doi: 10. 1111/sms. 12320.
33. Li, S., and Strittmatter, S. M. (2003). Delayed systemic Nogo-66 receptor antagonist promotes recovery from spinal cord injury. J. Neurosci. 23, 4219-4227.
34. Ling, S. C., Polymenidou, M., and Cleveland, D. W. (2013). Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis. Neuron 79, 416-438. doi: 10. 1016/j. neuron. 2013. 07. 033.
35. Martinez, H. R., Gonzalez-Garza, M. T., Moreno-Cuevas, J. E., Caro, E., Gutierrez-Jimenez, E., and Segura, J. J. (2009). Stem-cell transplantation into the frontal motor cortex in amyotrophic lateral sclerosis patients. Cytotherapy 11, 26-34. doi: 10. 1080/14653240802644651.
36. Mishina, Y., Starbuck, M. W., Gentile, M. A., Fukuda, T., Kasparcova, V., Seedor, J. G., et al. (2004). Bone morphogenetic protein type IA receptor signaling regulates postnatal osteoblast function and bone remodeling. J. Biol. Chem. 279, 27560-27566. doi: 10. 1074/jbc. M404222200.
37. Motomura, W., Yoshizaki, T., Ohtani, K., Okumura, T., Fukuda, M., Fukuzawa, J., et al. (2008). Immunolocalization of a novel collectin CL-K1 in murine tissues. J. Histochem. Cytochem. 56, 243-252. doi: 10. 1369/jhc. 7A7312. 2007.
38. Naumenko, N., Pollari, E., Kurronen, A., Giniatullina, R., Shakirzyanova, A., Magga, J., et al. (2011). Gender-Specific mechanism of synaptic impairment and its prevention by GCSF in a mouse model of ALS. Front. Cellular Neurosci. 5: 26. doi: 10. 3389/fncel. 2011. 00026.
39. Nefussy, B., Artamonov, I., Deutsch, V., Naparstek, E., Nagler, A., and Drory, V. E. (2010). Recombinant human granulocyte-colony stimulating factor administration for treating amyotrophic lateral sclerosis: a pilot study. Amyotroph. Lateral Scler. 11, 187-193. doi: 10. 3109/17482960902933809.
40. Numajiri, T., Mitsui, S., Hisa, Y., Ishida, T., Nishino, K., and Yamaguchi, N. (2009). The expression of a motoneuron-specific serine protease, motopsin (PRSS12), after facial nerve axotomy in mice. J. Plast. Reconstr. Aesthet. Surg. 59, 393-397. doi: 10. 1016/j. bjps. 2005. 04. 018.
41. Ohtani, K., Suzuki, Y., and Wakamiya, N. (2012). Biological functions of the novel collectins CL-L1, CL-K1, and CL-P1. J. Biomed. Biotechnol. 2012: 493945. doi: 10. 1155/2012/493945.
42. Perrin, F. E., Boisset, G., Docquier, M., Schaad, O., Descombes, P., and Kato, A. C. (2005). No widespread induction of cell death genes occurs in pure motoneurons in an amyotrophic lateral sclerosis mouse model. Hum. Mol. Genet. 14, 3309-3320. doi: 10. 1093/hmg/ddi357.
43. Philips, T., and Robberecht, W. (2011). Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease. Lancet Neurol. 10, 253-263. doi: 10. 1016/S1474-4422(11)70015-1.
44. Pitzer, C., Kruger, C., Plaas, C., Kirsch, F., Dittgen, T., Muller, R., et al. (2008). Granulocyte-colony stimulating factor improves outcome in a mouse model of amyotrophic lateral sclerosis. Brain 131(Pt 12), 3335-3347. doi: 10. 1093/brain/awn243.
45. Pollari, E., Savchenko, E., Jaronen, M., Kanninen, K., Malm, T., Wojciechowski, S., et al. (2011). Granulocyte colony stimulating factor attenuates inflammation in a mouse model of amyotrophic lateral sclerosis. J. Neuroinflammation 8: 74. doi: 10. 1186/1742-2094-8-74.
46. Pradhan, S. J., Nesler, K. R., Rosen, S. F., Kato, Y., Nakamura, A., Ramaswami, M., et al. (2012). The conserved P body component HPat/Pat1 negatively regulates synaptic terminal growth at the larval Drosophila neuromuscular junction. J, Cell Sci. 125(Pt 24), 6105-6116. doi: 10. 1242/jcs. 113043.
47. Sahni, V., Mukhopadhyay, A., Tysseling, V., Hebert, A., Birch, D., McGuire, T. L., et al. (2010). BMPR1a and BMPR1b signaling exert opposing effects on gliosis after spinal cord injury. J. Neurosci. 30, 1839-1855. doi: 10. 1523/JNEUROSCI. 4459-09. 2010.
48. Saris, C. G., Groen, E. J., Koekkoek, J. A., Veldink, J. H., and van den Berg, L. H. (2013). Meta-analysis of gene expression profiling in amyotrophic lateral sclerosis: a comparison between transgenic mouse models and human patients. Amyotroph. Lateral Scler. Frontotemporal Degener. 14, 177-189. doi: 10. 3109/21678421. 2012. 729842.
49. Schmitt, F., Hussain, G., Dupuis, L., Loeffler, J. P., and Henriques, A. (2014). A plural role for lipids in motor neuron diseases: energy, signaling and structure. Front. Cell. Neurosci. 8: 25. doi: 10. 3389/fncel. 2014. 00025.
50. Sleigh, J. N., Barreiro-Iglesias, A., Oliver, P. L., Biba, A., Becker, T., Davies, K. E., et al. (2014). Chondrolectin affects cell survival and neuronal outgrowth in in vitro and in vivo models of spinal muscular atrophy. Hum. Mol. Genet., 23, 855-869. doi: 10. 1093/hmg/ddt477.
51. Starkey, M. L., Davies, M., Yip, P. K., Carter, L. M., Wong, D. J., McMahon, S. B., et al. (2009). Expression of the regeneration-associated protein SPRR1A in primary sensory neurons and spinal cord of the adult mouse following peripheral and central injury. J. Comp. Neurol. 513, 51-68. doi: 10. 1002/cne. 21944.
52. Taylor, B. K., Fu, W., Kuphal, K. E., Stiller, C. O., Winter, M. K., Chen, W., et al. (2014). Inflammation enhances Y1 receptor signaling, neuropeptide Y-mediated inhibition of hyperalgesia, and substance P release from primary afferent neurons. Neuroscience 256, 178-194. doi: 10. 1016/j. neuroscience. 2013. 10. 054.
53. Tsujii, M., Akeda, K., Iino, T., and Uchida, A. (2009). Are BMPs involved in normal nerve and following transection?: a pilot study. Clin. Orthop. Relat. Res. 467, 3183-3189. doi: 10. 1007/s11999-009-1009-1.
54. Tsujino, H., Kondo, E., Fukuoka, T., Dai, Y., Tokunaga, A., Miki, K., et al. (2000). Activating transcription factor 3 (ATF3) induction by axotomy in sensory and motoneurons: a novel neuronal marker of nerve injury. Mol. Cell. Neurosci. 15, 170-182. doi: 10. 1006/mcne. 1999. 0814.
55. Turner, M. R., Bowser, R., Bruijn, L., Dupuis, L., Ludolph, A., McGrath, M., et al. (2013). Mechanisms, models and biomarkers in amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Frontotemporal Degener. 14, 19-32. doi: 10. 3109/21678421. 2013. 778554.
56. Wang, J., Duncan, D., Shi, Z., and Zhang, B. (2013). WEB-based GEne SeT AnaLysis Toolkit (WebGestalt): update 2013. Nucleic Acids Res. 41, W77-W83. doi: 10. 1093/nar/gkt439.
57. Wills, A. M., Hubbard, J., Macklin, E. A., Glass, J., Tandan, R., Simpson, E. P., et al. (2014). Hypercaloric enteral nutrition in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled phase 2 trial. Lancet. 383, 2065-2072. doi: 10. 1016/S0140-6736(14)60222-1.
58. Xiao, L., Michalski, N., Kronander, E., Gjoni, E., Genoud, C., Knott, G., et al. (2013). BMP signaling specifies the development of a large and fast CNS synapse. Nat. Neurosci. 16, 856-864. doi: 10. 1038/nn. 3414.
59. Yang, B. B., Savin, M. A., and Green, M. (2012). Prevention of chemotherapy-induced neutropenia with pegfilgrastim: pharmacokinetics and patient outcomes. Chemotherapy 58, 387-398. doi: 10. 1159/000345626.
60. Yang, R., Gaidamakov, S. A., Xie, J., Lee, J., Martino, L., Kozlov, G., et al. (2011). La-related protein 4 binds poly(A), interacts with the poly(A)-binding protein MLLE domain via a variant PAM2w motif, and can promote mRNA stability. Mol. Cell. Biol. 31, 542-556. doi: 10. 1128/MCB. 01162-10.
61. Zhang, B., Kirov, S., and Snoddy, J. (2005). WebGestalt: an integrated system for exploring gene sets in various biological contexts. Nucleic Acids Res. 33, W741-W748. doi: 10. 1093/nar/gki475.
62. Zhang, Y., Wang, L., Fu, Y., Song, H., Zhao, H., Deng, M., et al. (2009). Preliminary investigation of effect of granulocyte colony stimulating factor on amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. 10, 430-431. doi: 10. 3109/17482960802588059.
63. Zhong, Z., Ohnmacht, J., Reimer, M. M., Bach, I., Becker, T., and Becker, C. G. (2012). Chondrolectin mediates growth cone interactions of motor axons with an intermediate target. J. Neurosci. 32, 4426-4439. doi: 10. 1523/JNEUROSCI. 5179-11. 2012.